Mark Masterson is a leading pharmaceutical executive with over 20 years of experience across multiple geographies.
Mr Masterson held a number of senior roles during his time with global NYSE-listed healthcare giant Abbott Laboratories including leadership positions across the US, Europe, Asia and Australia. He was subsequently promoted to vice president of commercial operations in Asia and became a corporate officer for the group. Following that, Mr Masterson became chief executive of I-MED, Australia’s largest private diagnostic imaging network, and concluded his four-year tenure following the sale of the business to new owners. He then became chair of Medicines Australia, the leading representative body for discovery-driven pharmaceutical companies in Australia.
